Inborn errors of immunity associated with characteristic phenotypes
暂无分享,去创建一个
[1] A. Gennery,et al. Update on DNA-Double Strand Break Repair Defects in Combined Primary Immunodeficiency , 2020, Current Allergy and Asthma Reports.
[2] O. Mäkitie,et al. Immunodeficiency in cartilage‐hair hypoplasia: Pathogenesis, clinical course and management , 2020, Scandinavian journal of immunology.
[3] K. Schwarz,et al. T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency , 2020, Journal of Clinical Immunology.
[4] J. Casanova,et al. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee , 2020, Journal of Clinical Immunology.
[5] A. Aghamohammadi,et al. Ataxia‐telangiectasia: A review of clinical features and molecular pathology , 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[6] A. Worth,et al. How I manage patients with Wiskott Aldrich syndrome , 2019, British journal of haematology.
[7] A. Aghamohammadi,et al. The First Purine Nucleoside Phosphorylase Deficiency Patient Resembling IgA Deficiency and a Review of the Literature , 2019, Immunological investigations.
[8] A. Freeman,et al. An Update on Syndromes with a Hyper-IgE Phenotype. , 2019, Immunology and allergy clinics of North America.
[9] K. Sullivan. Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome , 2019, Immunological reviews.
[10] H. Ochs,et al. Hyper IgE syndromes: clinical and molecular characteristics , 2018, Immunology and cell biology.
[11] K. Sullivan,et al. Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome , 2018, American journal of medical genetics. Part A.
[12] J. Casanova,et al. Human hyper-IgE syndrome: singular or plural? , 2018, Mammalian Genome.
[13] A. Zauber,et al. Health supervision for people with Bloom syndrome , 2018, American journal of medical genetics. Part A.
[14] J. Bussel,et al. Screening for Wiskott-Aldrich syndrome by flow cytometry. , 2018, The Journal of allergy and clinical immunology.
[15] A. Schäffer,et al. ZNF341 controls STAT3 expression and thereby immunocompetence , 2018, Science Immunology.
[16] T. Crawford,et al. Chromosome instability syndromes , 2018, Nature Reviews Disease Primers.
[17] D. Campbell,et al. Immunodeficiency in CHARGE syndrome , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.
[18] K. Sullivan,et al. The immune deficiency of chromosome 22q11.2 deletion syndrome , 2017, American journal of medical genetics. Part A.
[19] Kim Blake,et al. CHARGE Syndrome , 2017, Pediatrics in Review.
[20] T. Crawford,et al. Ataxia telangiectasia: a review , 2016, Orphanet Journal of Rare Diseases.
[21] Colin A. Johnson,et al. A homozygous STIM1 mutation impairs store-operated calcium entry and natural killer cell effector function without clinical immunodeficiency , 2016, The Journal of allergy and clinical immunology.
[22] D. Lewis,et al. Schimke Immunoosseous Dysplasia , 2016 .
[23] G. Matthijs,et al. Clinical Utility Gene Card for: PGM3 defective congenital disorder of glycosylation , 2015, European Journal of Human Genetics.
[24] C. Boerkoel,et al. Insights into the Renal Pathogenesis in Schimke Immuno-Osseous Dysplasia , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[25] Peter Hsu,et al. CHARGE syndrome: A review , 2014, Journal of paediatrics and child health.
[26] D. Buchbinder,et al. Wiskott–Aldrich syndrome: diagnosis, current management, and emerging treatments , 2014, The application of clinical genetics.
[27] A. Cohen,et al. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies , 2013, Current opinion in allergy and clinical immunology.
[28] R. Geha,et al. Wiskott‐Aldrich syndrome: a comprehensive review , 2013, Annals of the New York Academy of Sciences.
[29] Amos J. Simon,et al. Purine nucleoside phosphorylase deficiency presenting as severe combined immune deficiency , 2013, Immunologic research.
[30] S. Ehl,et al. The European internet‐based patient and research database for primary immunodeficiencies: update 2011 , 2012, Clinical and experimental immunology.
[31] L. Fairbanks,et al. Purine Nucleoside Phosphorylase Deficiency: A Mutation Update , 2011, Nucleosides, nucleotides & nucleic acids.
[32] E. McDermott,et al. A novel NEMO gene mutation causing osteopetrosis, lymphoedema, hypohidrotic ectodermal dysplasia and immunodeficiency (OL-HED-ID) , 2010, European Journal of Pediatrics.
[33] V. Micheli,et al. Pediatric neurological syndromes and inborn errors of purine metabolism , 2010, Neurochemistry International.
[34] A. Fischer,et al. ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. , 2009, The Journal of allergy and clinical immunology.
[35] A. Verloes. Updated diagnostic criteria for CHARGE syndrome: A proposal , 2005, American journal of medical genetics. Part A.
[36] R. Gatti,et al. Ataxia-telangiectasia, an evolving phenotype. , 2004, DNA repair.
[37] O. Mäkitie. Cartilage-hair hypoplasia in Finland: epidemiological and genetic aspects of 107 patients. , 1992, Journal of medical genetics.